SOUTH SAN FRANCISCO, Calif., July 10, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation, a leader in mass cytometry and microfluidics technologies, today announced a new bimodal single‑cell application ...
Fluidigm received two grants (2008 and 2011) from the California Institute for Regenerative Medicine (CIRM) to develop a cell culture chip and support system to accelerate stem cell research, with the ...
This image shows the integrated fluidic circuit for the Fluidigm C1 system. Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results